Does UROFOLLITROPIN Cause Off label use? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Off label use have been filed in association with UROFOLLITROPIN. This represents 5.0% of all adverse event reports for UROFOLLITROPIN.
5
Reports of Off label use with UROFOLLITROPIN
5.0%
of all UROFOLLITROPIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Off label use From UROFOLLITROPIN?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UROFOLLITROPIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does UROFOLLITROPIN Cause?
Ovarian hyperstimulation syndrome (73)
Abdominal distension (25)
Abdominal pain (20)
Ascites (13)
Nausea (12)
Chest discomfort (10)
Dyspnoea (10)
Vomiting (10)
Oliguria (7)
Pelvic fluid collection (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which UROFOLLITROPIN Alternatives Have Lower Off label use Risk?
UROFOLLITROPIN vs URSODIOL
UROFOLLITROPIN vs USTEKINUMAB
UROFOLLITROPIN vs USTEKINUMAB-STBA
UROFOLLITROPIN vs VADADUSTAT
UROFOLLITROPIN vs VALACYCLOVIR